No Pharmacokinetic Interaction Between the Hepatitis C Virus Inhibitors Elbasvir/Grazoprevir and Famotidine or Pantoprazole

Use of agents to suppress gastric acid secretion is common among patients with hepatitis C virus (HCV) infection. The aims of this open‐label, three‐period, fixed‐sequence study were to evaluate the effect of famotidine and pantoprazole on the pharmacokinetics and safety of elbasvir/grazoprevir fixe...

Full description

Saved in:
Bibliographic Details
Published in:Clin Transl Sci
Main Authors: Feng, H‐P, Vaddady, P, Guo, Z, Liu, F, Panebianco, D, Levine, V, Caro, L, Butterton, JR, Iwamoto, M, Yeh, WW
Format: Artigo
Language:Inglês
Published: John Wiley and Sons Inc. 2017
Subjects:
Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5593162/
https://ncbi.nlm.nih.gov/pubmed/28625018
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cts.12465
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items